BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2030102)

  • 1. The changing horizon in the treatment of depression: scientific/clinical publication overview.
    Stokes PE
    J Clin Psychiatry; 1991 May; 52 Suppl():35-43. PubMed ID: 2030102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexisting depression and anxiety: special diagnostic and treatment issues.
    Lydiard RB
    J Clin Psychiatry; 1991 Jun; 52 Suppl():48-54. PubMed ID: 2050649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of comorbid anxiety and depression.
    Zajecka JM; Ross JS
    J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontricyclic antidepressants: current trends in children and adolescents.
    Emslie GJ; Walkup JT; Pliszka SR; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):517-28. PubMed ID: 10230183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine in the treatment of panic disorder and its complications.
    Liebowitz MR
    Psychiatr Clin North Am; 1985 Mar; 8(1):37-47. PubMed ID: 3887338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.
    Castaneda AE; Tuulio-Henriksson A; Marttunen M; Suvisaari J; Lönnqvist J
    J Affect Disord; 2008 Feb; 106(1-2):1-27. PubMed ID: 17707915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the long-term treatment of depression.
    Hirschfeld RM
    J Clin Psychiatry; 1994 Dec; 55 Suppl():61-9; discussion 70-1. PubMed ID: 7814359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The drug treatment of panic disorder.
    Matuzas W; Jack E
    Psychiatr Med; 1991; 9(2):215-43. PubMed ID: 1677479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New indications for antidepressants.
    Schatzberg AF
    J Clin Psychiatry; 2000; 61 Suppl 11():9-17. PubMed ID: 10926050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.